Related Experiment Video
Updated: Jul 15, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
Published on: February 9, 2011
An infection with linezolid-resistant S. aureus in a patient with left ventricular assist system
Axel Kola1, Philip Kirschner, Bernhard Gohrbandt
1Institute of Medical Microbiology and Hospital Epidemiology, Hannover, Germany. kola.axel@mh-hannover.de
Abstract:
We report an infection with a linezolid-resistant S. aureus in a patient with a left ventricular assist system. Linezolid should be used with caution when invasive devices or foreign materials are in place or therapeutic courses last longer than 14 d. Previous cases of linezolid-resistant S. aureus are summarized.
Insights
A patient with a left ventricular assist device developed a linezolid-resistant Staphylococcus aureus infection. Caution is advised when using linezolid with invasive devices or for extended durations.
Area of Science:
- Infectious Diseases
- Antimicrobial Resistance
- Cardiology
Background:
- Invasive cardiovascular devices, such as left ventricular assist systems (LVAS), are associated with a risk of device-related infections.
- Staphylococcus aureus is a common pathogen causing device-related infections.
- Linezolid is a critical antibiotic for treating serious Gram-positive infections, including those caused by MRSA.
Observation:
- A case of infection with linezolid-resistant Staphylococcus aureus (LRSA) is reported in a patient with an LVAS.
- The patient's infection highlights a significant challenge in treating device-associated infections.
Findings:
- The emergence of linezolid resistance in Staphylococcus aureus poses a therapeutic challenge, particularly in patients with indwelling medical devices.
- Previous documented cases of LRSA are summarized, indicating a growing concern.
Implications:
- Linezolid should be used with caution in patients with invasive devices or foreign materials.
- Extended therapeutic courses of linezolid (>14 days) may increase the risk of resistance development.
- Vigilance and alternative treatment strategies are necessary for LRSA infections in high-risk patients.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Endocarditis IV: Nursing Management
Cardiomyopathy V: Interprofessional Care
Endocarditis III: Medical Management
Endocarditis I: Introduction